Orexo AB (ORX) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.091x

Based on the latest financial reports, Orexo AB (ORX) has a cash flow conversion efficiency ratio of -0.091x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-33.30 Million ≈ $-3.58 Million USD) by net assets (Skr364.70 Million ≈ $39.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Orexo AB to measure how much of total assets are equity-financed.

Orexo AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Orexo AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Orexo AB to evaluate the quality of earnings relative to operating cash generation.

Orexo AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orexo AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mobiis Co. Ltd KQ:250060	0.010x
Remed Co.Ltd KQ:302550	0.006x
Kanpur Plastipack Limited NSE:KANPRPLA	0.057x
G5 Entertainment publ AB ST:G5EN	-0.006x
MFO SA WAR:MFO	0.062x
Choheung KO:002600	0.180x
FoundPac Group Bhd KLSE:5277	0.072x
Aeon Motor Co Ltd TWO:1599	0.066x

Annual Cash Flow Conversion Efficiency for Orexo AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Orexo AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ORX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr490.60 Million ≈ $52.80 Million	Skr173.00 Million ≈ $18.62 Million	0.353x	+36.62%
2024-12-31	Skr-126.30 Million ≈ $-13.59 Million	Skr-32.60 Million ≈ $-3.51 Million	0.258x	+116.00%
2023-12-31	Skr58.90 Million ≈ $6.34 Million	Skr-95.00 Million ≈ $-10.22 Million	-1.613x	-99.71%
2022-12-31	Skr193.90 Million ≈ $20.87 Million	Skr-156.60 Million ≈ $-16.85 Million	-0.808x	-23.30%
2021-12-31	Skr349.60 Million ≈ $37.62 Million	Skr-229.00 Million ≈ $-24.64 Million	-0.655x	-2277.60%
2020-12-31	Skr558.50 Million ≈ $60.10 Million	Skr16.80 Million ≈ $1.81 Million	0.030x	-92.60%
2019-12-31	Skr706.40 Million ≈ $76.02 Million	Skr287.00 Million ≈ $30.89 Million	0.406x	-20.07%
2018-12-31	Skr476.10 Million ≈ $51.24 Million	Skr242.00 Million ≈ $26.04 Million	0.508x	+14.11%
2017-12-31	Skr329.10 Million ≈ $35.42 Million	Skr146.60 Million ≈ $15.78 Million	0.445x	-11.51%
2016-12-31	Skr310.30 Million ≈ $33.39 Million	Skr156.20 Million ≈ $16.81 Million	0.503x	+231.25%
2015-12-31	Skr266.46 Million ≈ $28.68 Million	Skr-102.19 Million ≈ $-11.00 Million	-0.384x	+64.19%
2014-12-31	Skr455.02 Million ≈ $48.97 Million	Skr-487.30 Million ≈ $-52.44 Million	-1.071x	+34.30%
2013-12-31	Skr161.46 Million ≈ $17.38 Million	Skr-263.20 Million ≈ $-28.32 Million	-1.630x	-1187.18%
2012-12-31	Skr191.19 Million ≈ $20.58 Million	Skr28.67 Million ≈ $3.09 Million	0.150x	+139.79%
2011-12-31	Skr311.10 Million ≈ $33.48 Million	Skr-117.23 Million ≈ $-12.62 Million	-0.377x	-310.64%
2010-12-31	Skr468.24 Million ≈ $50.39 Million	Skr-42.97 Million ≈ $-4.62 Million	-0.092x	+62.41%
2009-12-31	Skr548.66 Million ≈ $59.04 Million	Skr-133.93 Million ≈ $-14.41 Million	-0.244x	-37.04%
2008-12-31	Skr569.78 Million ≈ $61.32 Million	Skr-101.49 Million ≈ $-10.92 Million	-0.178x	+25.50%
2007-12-31	Skr671.25 Million ≈ $72.24 Million	Skr-160.49 Million ≈ $-17.27 Million	-0.239x	-206.76%
2006-12-31	Skr324.35 Million ≈ $34.91 Million	Skr-25.28 Million ≈ $-2.72 Million	-0.078x	+41.80%
2005-12-31	Skr338.91 Million ≈ $36.47 Million	Skr-45.38 Million ≈ $-4.88 Million	-0.134x	+33.29%
2004-12-31	Skr79.44 Million ≈ $8.55 Million	Skr-15.94 Million ≈ $-1.72 Million	-0.201x	+73.90%
2003-12-31	Skr35.88 Million ≈ $3.86 Million	Skr-27.59 Million ≈ $-2.97 Million	-0.769x	+5.68%
2002-12-31	Skr25.52 Million ≈ $2.75 Million	Skr-20.80 Million ≈ $-2.24 Million	-0.815x	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$54.74 Million

Skr508.64 Million SEK

Market Cap Rank

#21499 Global

#398 in Sweden

Share Price

Skr14.48

Change (1 day)

-1.50%

52-Week Range

Skr14.36 - Skr41.60

All Time High

Skr85.70